Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
Appointed director
Asset disposition
Credit agrmnt [a]
|
|
SURMODICS INC (SRDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/26/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 04/26/2023 |
8-K
| Quarterly results |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/15/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/13/2023 |
8-K
| Quarterly results |
| 02/06/2023 |
8-K
| Quarterly results |
| 02/03/2023 |
8-K
| Quarterly results |
| 01/19/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 11/09/2022 |
8-K
| Quarterly results |
| 10/17/2022 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...|
Docs:
|
"Credit, Security and Guaranty Agreement by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Holdings, LLC, Surmodics Coatings, LLC, SurModics MD, LLC, Surmodics Coatings Mfg, LLC, Surmodics IVD, Inc., NorMedix, Inc., and Surmodics MD Operations, LLC, as borrowers, the guarantors from time to time party thereto, MidCap Funding IV Trust and MidCap Financial Trust and the lenders from time to time party thereto (excluding schedules and exhibits which Surmodics, Inc. agrees to furnish to the Securities and Exchange Commission upon request and certain personal information)",
"Credit, Security and Guaranty Agreement by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Holdings, LLC, Surmodics Coatings, LLC, SurModics MD, LLC, Surmodics Coatings Mfg, LLC, Surmodics IVD, Inc., NorMedix, Inc., and Surmodics MD Operations, LLC, as borrowers, the guarantors from time to time party thereto, MidCap Funding IV Trust and MidCap Financial Trust and the lenders from time to time party thereto (excluding schedules and exhibits which Surmodics, Inc. agrees to furnish to the Securities and Exchange Commission upon request and certain personal information)" |
|
| 08/31/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/27/2022 |
8-K
| Quarterly results |
| 04/27/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/07/2022 |
8-K
| Quarterly results |
| 02/14/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 02/03/2022 |
8-K
| Quarterly results |
| 01/11/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 11/10/2021 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/04/2021 |
8-K
| Quarterly results |
| 07/06/2021 |
8-K
| Investor presentation, Credit agreement amendment|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AGREEMENT FOR THE SALE AND PURCHASE OF SHARES IN THE CAPITAL OF VETEX MEDICAL LIMITED THE PERSONS WHOSE NAMES ARE SET OUT IN SCHEDULE 1 MARK BRUZZI SONASIAR LIMITED SURMODICS MD, LLC SURMODICS, INC. DATED 2 JULY 2021",
"SURMODICS MD, LLC, a limited liability company organized under the laws of Minnesota with file number 852133900023 and having its registered office at 9924 West 74th Street, Eden Prairie, MN, 55344 ; and THE PERSONS WHOSE NAMES AND ADDRESSES ARE SET OUT IN SCHEDULE 1 . BACKGROUND Pursuant to a share purchase agreement of today’s date in respect of shares in the issued share capital of the Company the Buyer agreed to purchase, and the Sellers agreed to sell, the Shares, comprising the entire issued share capital of Vetex Medical Limited excluding the beneficial interest only in the Put and Call Shares. The Sellers and the Buyer have agreed to enter into put and call options in relation to the beneficial interest in the Put and Call Shares on the terms and subject to the conditions set out i...",
"FIRST AMENDMENT TO",
"Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited",
"ARTERIAL CLOT REMOVAL U.S. MARKET" |
|
| 04/28/2021 |
8-K
| Quarterly results |
| 02/16/2021 |
8-K
| Quarterly results |
| 02/09/2021 |
8-K
| Quarterly results |
| 01/28/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 11/18/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/04/2020 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 09/23/2020 |
8-K
| Quarterly results |
| 09/15/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Loan and Security Agreement by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Coatings, LLC, Surmodics Coatings Mfg, LLC, Surmodics IVD, Inc., NorMedix, Inc., Surmodics MD Operations, LLC and Bridgewater Bank",
"Loan and Security Agreement by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Coatings, LLC, Surmodics Coatings Mfg, LLC, Surmodics IVD, Inc., NorMedix, Inc., Surmodics MD Operations, LLC and Bridgewater Bank" |
|
| 08/05/2020 |
8-K
| Quarterly results |
| 07/23/2020 |
8-K
| Quarterly results |
| 06/08/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 04/29/2020 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
|
|
|